Episode
Episode 173 - Jason Silvers, President & CFO & Laurie Lee, CMO (I&I) - Generate: Biomedicines
- Podcast
- The BioHub - by Avetix
- Published
- May 14, 2026
- Duration seconds
- 2371
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-173-jason-silvers-president-cfo-laurie-lee-cmo-i-i-generate-biomedicines/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-173-jason-silvers-president-cfo-laurie-lee-cmo-i-i-generate-biomedicines.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of The BioHub Podcast, Amber is joined by Jason Silvers, President & CFO at Generate:Biomedicines, and Laurie Lee, CMO for Immunology & Inflammation. Following Generate’s recent IPO, the conversation explores what it actually looks like to scale an AI-native biotech into late-stage clinical development. Amber, Jason, and Laurie discuss GB-0895 (anti-TSLP) and the global SOLAIRIA Phase 3 programme in severe asthma, designing and testing proteins at scale, and the operational realities of building across AI, experimental biology, and clinical development. The episode also explores how the wider AI x biotech landscape is shifting from platform potential to real clinical execution.